NEW YORK, June 29 (GenomeWeb News) - Genedata will continue to provide Altana Pharma with its scientific computational platform, the Basel, Switzerland-based company said today.
Under the expanded collaboration, Altana will use Genedata's platform for target identification, target validation, and lead discovery.
Altana first licensed the platform five years ago for its research sites in Constance, Germany, and Waltham, Mass.